Skip to main content

Advertisement

Log in

New predictive nomograms for non-muscle-invasive bladder cancer: it is all about the details

  • Letter to Editor
  • Published:
World Journal of Urology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Kim HS, Jeong CW, Kwak C et al (2018) Novel nomograms to predict recurrence and progression in primary non-muscle-invasive bladder cancer: validation of predictive efficacy in comparison with European organization of research and treatment of cancer scoring system. World J Urol. https://doi.org/10.1007/s00345-018-2581-3

    Article  PubMed  Google Scholar 

  2. Mikulowski P, Hellsten S (2005) T1 G1 urinary bladder carcinoma: fact or fiction? Scand J Urol Nephrol 39:135–137. https://doi.org/10.1080/00365590510031219

    Article  PubMed  Google Scholar 

  3. Cookson MS, Herr HW, Zhang ZF et al (1997) The treated natural history of high risk superficial bladder cancer: 15-year outcome. J Urol 158:62–67. https://doi.org/10.1097/00005392-199707000-00017

    Article  CAS  PubMed  Google Scholar 

  4. Mathieu R, Lucca I, Roupret M et al (2016) The prognostic role of lymphovascular invasion in urothelial carcinoma of the bladder. Nat Rev Urol 13:471–479. https://doi.org/10.1038/nrurol.2016.126

    Article  CAS  PubMed  Google Scholar 

  5. Wasco MJ, Daignault S, Zhang Y et al (2007) Urothelial carcinoma with divergent histologic differentiation (mixed histologic features) predicts the presence of locally advanced bladder cancer when detected at transurethral resection. Urology 70:69–74. https://doi.org/10.1016/j.urology.2007.03.033

    Article  PubMed  Google Scholar 

  6. Singla N, Fang D, Su X et al (2017) A multi-institutional comparison of clinicopathological characteristics and oncologic outcomes of upper tract urothelial carcinoma in China and the United States. J Urol 197:1208–1213. https://doi.org/10.1016/j.juro.2016.11.094

    Article  PubMed  Google Scholar 

  7. Babjuk M, Bohle A, Burger M et al (2017) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol 71:447–461. https://doi.org/10.1016/j.eururo.2016.05.041

    Article  PubMed  Google Scholar 

  8. Chou R, Selph S, Buckley DI et al (2017) intravesical therapy for the treatment of nonmuscle invasive bladder cancer: a systematic review and meta-analysis. J Urol 197:1189–1199. https://doi.org/10.1016/j.juro.2016.12.090

    Article  PubMed  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wojciech Krajewski.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

None.

Informed consent

None.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This letter refers to the original article available at doi: https://doi.org/10.1007/s00345-018-2581-3.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Krajewski, W., Rodríguez Faba, O., Poletajew, S. et al. New predictive nomograms for non-muscle-invasive bladder cancer: it is all about the details. World J Urol 38, 805–806 (2020). https://doi.org/10.1007/s00345-019-02680-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-019-02680-3

Navigation